DMD treatment in pigs

Guidelines for Corticosteroid use in Treatment of DMD

The guideline development subcommittee of the American Academy of Neurology has provided an update to the 2005 treatment guidelines for use of corticosteroids (CS) in Duchenne muscular dystrophy (DMD).

, Dmd

Prosthodontics, Scranton, Pennsylvania. ter of routine. However, in anterior implant -supported restorations, the successful achievement of the aesthetic goal can often be elusive. The task is made especially arduous when the potential implant recipient site lies within the lip perimeter and is compromised by significant hard and soft tissue defects and/or inharmonious occlusal combinations. Un...

DMD # 10249 1 Enzyme

Exon skipping for DMD

Duchenne muscular dystrophy (DMD) is a severe, progressive muscle-wasting disorder, while Becker muscular dystrophy (BMD) is milder muscle disease [1]. Both are caused by mutations in dystrophin, a protein, which stabilizes muscle fibers during contraction by linking muscle actin to the extracellular matrix. In DMD patients mutations disrupt the open reading frame, generating prematurely trunca...

ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice

Vascular endothelial growth factor (VEGF) and other pro-angiogenic growth factors have been investigated to enhance muscle tissue perfusion and repair in Duchenne muscular dystrophy (DMD). Current understanding is limited by a lack of functional data following in vivo delivery of these growth factors. We previously used dynamic contrast-enhanced computed tomography to monitor disease progressio...